$IMAX

StoneX reiterates Buy on Imax stock, sees record third quarter

StoneX maintained a Buy rating and $60 price target for IMAX (NYSE:IMAX), forecasting record Q3 box office revenue of $650M+ driven by strong performance of 'The Odyssey'. IMAX's Q2 earnings showed 65% YoY EPS growth to $0.43 and 12% revenue increase to $103M. Rosenblatt raised its target to $60, citing robust box office and system sales.

Original reporting
Published Sep 1, 2026, 1:16 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 1, 2026, 3:05 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$IMAX
Bullish
medium confidence
Mentioned
$IMAX
Relevance
4/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$IMAXBullishLow
01

Why it matters

Analyst price target raise reflects confidence in upcoming Q3 performance, but market may price in expectations already.

02

Market read

IMAX's strong box office and analyst upgrades could drive short-term price moves.

03

What to watch

Potential supply chain constraints on new IMAX system installations.

Relevance 4/10Novelty 3/10Timing: ahead of Q3 2026

Background

IMAX reported strong Q2 earnings and box office results, prompting analyst upgrades.

Company-level read

Ticker impact

$IMAXBullishMedium confidence
Context

StoneX reiterated a Buy rating and $60 price target, forecasting a record Q3 box office of $650M for IMAX.

Expected impact

Potential price appreciation toward $60 target.

Evidence & confidence

Box office outlook exceeds consensus, but valuation appears stretched.

Market effects

Strong IMAX performance may boost related entertainment and cinema equipment stocks.

Higher box office revenue in the U.S. and Greater China supports regional market sentiment.

Record Q3 outlook could influence global media and streaming sector sentiment.

Counterpoint

Valuation may be overextended; box office growth could slow if competition intensifies.

Key entities

  • StoneX

    Equity research firm issuing Buy rating and $60 target.

  • Rosenblatt

    Raised price target to $60 based on box office strength.

Related articles

$IMAXMed

IMAX at Bank of America 2026 Media,Communications & Entertainment Conference: global surge

IMAX Corporation (IMAX) reported strong global growth at the Bank of America 2026 Media, Communications & Entertainment Conference. CEO Rich Gelfond highlighted record box office performance, international expansion, and new revenue streams. Current-quarter box office is on track to exceed $600 million, with significant contributions from international markets and local-language films. The company operates 1,800 theaters, with 500 in backlog, and aims to expand further. IMAX is also diversifying

$IMAXMed

Why IMAX Stock Climbed to a New All-Time High Today

IMAX stock reached a new all-time high on Monday, rising 3.89% to $54.79. The surge was driven by the record-breaking success of The Odyssey, which became the highest-grossing IMAX release. CEO Rich Gelfond expects this to be their best year. Analyst Steve Frankel predicts IMAX will exceed estimates in the second half of 2026, with shares potentially rising to $60. The company's Q2 2026 revenue grew 12% to $103 million, with adjusted earnings up 65% to $0.43 per share.

$IMAXMed

“The Odyssey” Demand Drives IMAX Shares Higher

IMAX reported Q2 2026 revenue of $103M (up 12% YoY) and EPS of $0.43 (up 65%), driven by strong demand for 'The Odyssey'. The stock has gained 42% YTD, with institutional inflows contributing to a 103.5% rise over the past year. IMAX shows strong sales and EPS growth rates of 11.7% and 18.7% respectively over three years, with EPS expected to rise 14% this year.

$IMAXMed

Why IMAX Stock Rallied on Monday

IMAX shares rose about 5% on Monday after the company said Christopher Nolan’s film The Odyssey became the highest-grossing IMAX release of all time. IMAX reported $289 million in ticket sales, plus $37 million in the fourth weekend, and said IMAX theaters account for 26% of total tickets. IMAX added that 70mm locations have grossed over $37 million and presales near $40 million.

$IMAXMed

Why IMAX Stock Soared on Monday

IMAX said The Odyssey helped it post its highest-ever monthly box-office results, with July box-office revenue of $257 million, up 47% from the prior record. Ticket sales for The Odyssey totaled $221 million. IMAX also announced an upcoming run for Spider-Man: Brand New Day and shares closed Monday nearly 7% higher.